BioWorld MedTech

Sep. 2, 2014

Kona stakes claim in renal denervation space with WAVE IV clinical trial

Another company is staking its claim in developing a non-invasive approach toward treating hypertension. Kona Medical (Bellevue, Washington) is evaluating its Surround Sound Hypertension Therapy System through the WAVE IV clinical trial. Read More

Siemens brings real-time 3-D echo to valve procedures

ACR argues CT beats Cologuard; CMS waiting for USPSTF analysis

Taiwanese OEM giant Foxconn looking at medical equipment field

J&J reportedly seeking buyer for Cordis unit

Researchers alter memories from bad to good and vice versa

Catheter Connections denies all of competitor Ivera's allegations

Product Briefs

Briefly noted

Keeping you up to date on recent developments in Cardiology

Today's news in brief

BioWorld

BioWorld briefs for April 17, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 17, 2025.

ADPD 2025: Novel treatment modalities in neurodegenerative disorders

BioWorld Science

The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease...

Many US tariffs paused, pharma warned, EU put on notice

BioWorld

The on-again, off-again U.S. tariffs are off again, at least for now, for more than 75 countries that have reached out to the Trump administration to negotiate...

Ouch! Tariffs hit med tech harder than expected

BioWorld MedTech

First quarter earnings reports from Johnson & Johnson and Abbott Laboratories provided some surprising insights into the likely hit med-tech companies will...